AstraZeneca Invests $2 Billion in Summit Therapeutics
MIAMI — September 28, 2026 Summit Therapeutics Inc. announced that AstraZeneca will make a $2 billion strategic equity investment...
diabetes
Advertisement
Kither Biotech Doses First Patients in KIT2014 COPD Trial
TURIN, Italy — September 29, 2026 Kither Biotech Pty Ltd and Kither Biotech Srl announced that the first patients...
Caspian Unveils KO-7246 Preclinical Diabetes Data at EASD
SAN DIEGO — September 29, 2026 Caspian Therapeutics and Kura Oncology announced new preclinical data for KO-7246, an investigational,...
Mirum Pharmaceuticals Wins FDA Approval for ATEBRIOZ
Foster City, California & Wilmington, Delaware, September 25, 2026 Mirum Pharmaceuticals and Incyte have announced a major regulatory milestone...
REGENXBIO Reports Three-Year Data for Surabgene in Retinopathy
Rockville, Maryland, U.S., September 24, 2026 REGENXBIO Inc. has presented three-year clinical data for surabgene lomparvovec in patients with...
Advertisements
Lakewood-Amedex Starts Phase 2a Trial of Nu-3 for Foot Ulcers
San Diego, California, U.S., September 24, 2026 Lakewood-Amedex Biotherapeutics has announced that the first patient has been dosed in...
Novo Nordisk Launches Novo Rebrand and New Corporate Culture
BAGSVAERD, Denmark — September 14, 2026 Novo Nordisk A/S announced the launch of a new corporate brand centred on...
Kura Oncology launches Caspian Therapeutics with $50M financing
SAN DIEGO — September 9, 2026 Kura Oncology, Inc. announced the launch of Caspian Therapeutics, Inc., a separately financed...
Ascletis Joins Hong Kong Stock Connect Programs
Hong Kong, September 7, 2026 Ascletis Pharma Inc. has announced that its ordinary shares have been included as eligible...
Modular Medical Expands Pivot Pump Access Through U.S. PBM Contract
San Diego, California — September 4, 2026 Modular Medical announced that it has secured a contract with a national...
Advertisement
